SG Americas Securities’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.9M Buy
195,668
+11,839
+6% +$2.18M 0.04% 364
2025
Q4
$32.4M Buy
183,829
+174,122
+1,794% +$28.4M 0.04% 341
2025
Q3
$1.36M Sell
9,707
-12,763
-57% -$1.73M ﹤0.01% 1202
2025
Q2
$2.82M Sell
22,470
-697,323
-97% -$86.9M 0.01% 644
2025
Q1
$98.5M Buy
+719,793
New +$103M 0.32% 39
2024
Q4
Sell
-3,675
Closed -$620K 3161
2024
Q3
$712K Sell
3,675
-36,515
-91% -$7.64M ﹤0.01% 1370
2024
Q2
$9.32M Sell
40,190
-136,072
-77% -$29.6M 0.05% 347
2024
Q1
$38M Buy
176,262
+162,083
+1,143% +$38M 0.18% 116
2023
Q4
$3.67M Sell
14,179
-2,387
-14% -$586K 0.03% 425
2023
Q3
$4.26M Sell
16,566
-1,489
-8% -$398K 0.05% 354
2023
Q2
$5.14M Buy
18,055
+4,570
+34% +$1.36M 0.04% 356
2023
Q1
$3.75M Sell
13,485
-13,700
-50% -$3.79M 0.04% 374
2022
Q4
$7.53M Buy
27,185
+20,213
+290% +$5.71M 0.09% 179
2022
Q3
$1.86M Sell
6,972
-2,301
-25% -$489K 0.02% 626
2022
Q2
$1.89M Sell
9,273
-56,121
-86% -$11.5M 0.02% 779
2022
Q1
$13.8M Buy
65,394
+32,639
+100% +$7.1M 0.1% 163
2021
Q4
$7.86M Buy
32,755
+11,456
+54% +$2.95M 0.04% 336
2021
Q3
$6.03M Buy
21,299
+8,455
+66% +$2.77M 0.03% 457
2021
Q2
$4.45M Sell
12,844
-17,157
-57% -$5.2M 0.02% 649
2021
Q1
$8.39M Sell
30,001
-30,168
-50% -$8.14M 0.04% 336
2020
Q4
$14.7M Buy
60,169
+28,332
+89% +$7.31M 0.08% 192
2020
Q3
$9.03M Sell
31,837
-23,366
-42% -$6.52M 0.06% 212
2020
Q2
$14.8M Buy
55,203
+46,308
+521% +$13.9M 0.12% 127
2020
Q1
$2.81M Sell
8,895
-13,217
-60% -$4.01M 0.03% 630
2019
Q4
$6.56M Sell
22,112
-33,640
-60% -$9.33M 0.06% 303
2019
Q3
$13M Sell
55,752
-17,829
-24% -$4.15M 0.11% 174
2019
Q2
$17.2M Buy
73,581
+29,500
+67% +$6.81M 0.12% 144
2019
Q1
$10.4M Buy
44,081
+34,669
+368% +$10.9M 0.1% 212
2018
Q4
$2.83M Sell
9,412
-44,414
-83% -$14.2M 0.02% 639
2018
Q3
$19M Buy
53,826
+20,884
+63% +$7.19M 0.14% 137
2018
Q2
$9.56M Buy
32,942
+5,997
+22% +$1.69M 0.09% 229
2018
Q1
$7.38M Sell
26,945
-4,743
-15% -$1.47M 0.06% 273
2017
Q4
$10.1M Buy
31,688
+1,281
+4% +$411K 0.09% 177
2017
Q3
$9.52M Buy
30,407
+25,156
+479% +$7.45M 0.08% 172
2017
Q2
$1.43M Sell
5,251
-38,972
-88% -$10.3M 0.01% 1135
2017
Q1
$12.1M Sell
44,223
-79,584
-64% -$22.5M 0.11% 180
2016
Q4
$35.1M Buy
123,807
+120,669
+3,845% +$35.8M 0.29% 64
2016
Q3
$982K Sell
3,138
-29,088
-90% -$8.62M 0.01% 1185
2016
Q2
$7.79M Sell
32,226
-51,665
-62% -$13.6M 0.06% 266
2016
Q1
$21.8M Sell
83,891
-16,497
-16% -$4.36M 0.16% 104
2015
Q4
$30.8M Sell
100,388
-61,160
-38% -$17.6M 0.22% 73
2015
Q3
$19.3M Buy
161,548
+66,072
+69% +$21.8M 0.12% 153
2015
Q2
$38.6M Sell
95,476
-19,263
-17% -$7.73M 0.25% 57
2015
Q1
$48.4M Sell
114,739
-61,806
-35% -$24.4M 0.29% 70
2014
Q4
$59.9M Sell
176,545
-74,760
-30% -$24.2M 0.29% 72
2014
Q3
$83.1M Buy
251,305
+27,317
+12% +$9.01M 0.49% 36
2014
Q2
$70.6M Sell
223,988
-44,472
-17% -$13.4M 0.41% 44
2014
Q1
$82.1M Buy
268,460
+6,766
+3% +$2.15M 0.36% 56
2013
Q4
$73.2M Sell
261,694
-27,976
-10% -$7.24M 0.3% 68
2013
Q3
$69.7M Buy
289,670
+13,952
+5% +$3.12M 0.29% 73
2013
Q2
$59.3M Buy
+275,718
New +$58.9M 0.29% 71

Other funds holding BIIB

SG Americas Securities's BIIB Position: Q1 2026 in Review

SG Americas Securities increased its Biogen (BIIB) stake by 6.4% in Q1 2026, buying an estimated $2.18M and bringing the position to 195,668 shares worth $35.9M. The position accounts for 0.04% of the portfolio, ranked #364.

SG Americas Securities first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. The position peaked at $98.5M in Q1 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • SG Americas Securities held 195,668 shares of Biogen worth $35.9M as of Q1 2026.
  • SG Americas Securities bought 11,839 Biogen shares in Q1 2026, an estimated $2.18M.
  • Biogen made up 0.04% of SG Americas Securities's portfolio in Q1 2026, its #364 holding.
  • SG Americas Securities first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
  • SG Americas Securities's Biogen position peaked at $98.5M in Q1 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.